Challenges in Assessing COVID-19 Vaccines Safety Signals—The Case of ChAdOx1 nCoV-19 Vaccine and Corneal Graft Rejection

The rapid and large-scale roll-out of new COVID-19 vaccines has led to unprecedented challenges in assessing vaccine safety. In 2021, the European Medicines Agency (EMA) processed about 1.7 million safety reports related to COVID-19 vaccines in the EudraVigilance (EV) database and identified more th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bizimungu, Christelle, Sabbe, Martine, Wuillaume, Françoise, Hamdani, Jamila, Koch, Philippe, Dogné, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221427/
https://www.ncbi.nlm.nih.gov/pubmed/37243058
http://dx.doi.org/10.3390/vaccines11050954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221427/
https://www.ncbi.nlm.nih.gov/pubmed/37243058
http://dx.doi.org/10.3390/vaccines11050954

Ejemplares similares